Achieve Life Sciences Inc (ACHV)

Achieve Life Sciences (ACHV) Stock Price & Analysis


ACHV Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.00 - $10.30
Previous Close$6.28
Average Volume (3M)180.30K
Market Cap
Enterprise Value$132.10M
Total Cash (Recent Filing)$16.51M
Total Debt (Recent Filing)$16.48M
Price to Earnings (P/E)-1.7
Aug 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.77
Shares Outstanding18,040,760
10 Day Avg. Volume385,529
30 Day Avg. Volume180,302
Standard Deviation0.29
Financial Highlights & Ratios
Price to Book (P/B)119.78
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.16
Price Target Upside274.20% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Achieve Life Sciences Inc’s price range in the past 12 months?
Achieve Life Sciences Inc lowest stock price was $2.00 and its highest was $10.30 in the past 12 months.
    What is Achieve Life Sciences Inc’s market cap?
    Currently, no data Available
    When is Achieve Life Sciences Inc’s upcoming earnings report date?
    Achieve Life Sciences Inc’s upcoming earnings report date is Aug 10, 2023 which is in 73 days.
      How were Achieve Life Sciences Inc’s earnings last quarter?
      Achieve Life Sciences Inc released its earnings results on May 09, 2023. The company reported -$0.5 earnings per share for the quarter, beating the consensus estimate of -$0.686 by $0.186.
        Is Achieve Life Sciences Inc overvalued?
        According to Wall Street analysts Achieve Life Sciences Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Achieve Life Sciences Inc pay dividends?
          Achieve Life Sciences Inc does not currently pay dividends.
          What is Achieve Life Sciences Inc’s EPS estimate?
          Achieve Life Sciences Inc’s EPS estimate is -$0.41.
            How many shares outstanding does Achieve Life Sciences Inc have?
            Achieve Life Sciences Inc has 21,040,760 shares outstanding.
              What happened to Achieve Life Sciences Inc’s price movement after its last earnings report?
              Achieve Life Sciences Inc reported an EPS of -$0.5 in its last earnings report, beating expectations of -$0.686. Following the earnings report the stock price went up 12.713%.
                Which hedge fund is a major shareholder of Achieve Life Sciences Inc?
                Currently, no hedge funds are holding shares in ACHV


                Achieve Life Sciences Stock Smart Score

                The Achieve Life Sciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Achieve Life Sciences Inc

                Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products, cytisine, is a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.


                Top 5 ETFs holding ACHV

                Market Value
                Smart Score
                iShares Core S&P Total U.S. Stock Market ETF
                Up to five ETFs with an Outperform Smart Score that hold ACHV. The ETFs are listed according to market value of ACHV within the ETF


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Lisata Therapeutics
                LungLife AI, Inc.
                Gelesis Holdings

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis